Charles River Laboratories Denmark ApS: Financial statements 2022
CVR: 42036099
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Charles River Laboratories Denmark ApS (CVR 42036099) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 3,825,068 and a net result of DKK 736,818 compared with DKK 841,688 the year before. That is a decrease of 30.9% compared with the year before. Equity in the 2022 report amounted to DKK 3,118,506. The solvency ratio was 91.3%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 3,825,068
- Profit/Loss
- DKK 736,818
- Equity
- DKK 3,118,506
- Total Assets
- DKK 3,414,185
- Employees
- 4
Official annual report
Keep an eye on Charles River Laboratories Denmark ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Charles River Laboratories Denmark ApS has published its annual report for 2021. Gross profit came to DKK 5,534,888, and the net result was DKK 841,688.
As of June 17, 2022, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Charles River Laboratories Denmark ApS.
About Charles River Laboratories Denmark ApS
Charles River Laboratories Denmark ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Brian Bathgate, Kerstin Dolph and Rushna Tejani Heneghan. The company is owned by Charles River Nederland B.V.. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 3,651,594 and a net result of DKK 74,021 compared with DKK 426,277 the year before. Equity in the 2025 report amounted to DKK 3,811,528.